FOR IMMEDIATE RELEASE                                                                            

Media Contact: Kristen Burke
November 17, 2016                                                                                                                


Home Oxygen Leaders Urge Congress to Enact Bill to Delay
Implementation of Home Oxygen Cuts

CQRC urges Congress to immediately reinstate the phase-in of Medicare cuts
and revise the methodology for setting rates to protect patients

WASHINGTON – The Council for Quality Respiratory Care (CQRC) –  a coalition of the nation’s leading home oxygen therapy provider and manufacturing companies – today urged lawmakers in Congress to prioritize enactment of provisions of the Patient Access to Durable Medical Equipment (PADME) Act before the end of the congressional session.  The PADME Act would reinstate the phase-in period of deep Medicare cuts to home respiratory care supplies and services. Both the Senate and House passed varying versions of the bill earlier this year, therefore requiring the chambers to come together on legislation to protect both patient access and quality of services.

“Congress clearly understands the vital importance of passing this bipartisan legislation. It’s time for leaders in the Senate and House to work together to enact the critical provisions of the bill,” said Dan Starck, Chairman of CQRC.   “It remains clear that more time is needed to adequately measure and monitor the impact of earlier cuts that took effect on January 1 before Medicare implements deeper cuts on home respiratory care.”

Senate passed legislationtpatient groups, physicians industry leaders Government Accountability Office (GAO) and the HHS Office of the Inspector General (OIG) have released reports calling competitive bid rates and their application into question.

Home respiratory therapy supplies and services are vital to managing Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary conditions.  Data show home oxygen care reduces preventable hospitalizations and readmissions, signaling that reduced access to quality respiratory care in the home will result in increased emergency room (ER) visits and readmissions, therefore harming patient outcomes and increasing Medicare costs.

“The Congress must act now to ensure a bill reinstating the phase-in is signed into law,” added Starck.  “It is also important that CMS take into account the differences between competitive bid and noncompetitive bid areas when setting noncompetitive bid rates in the future.”


To learn more, visit and follow CQRC on Twitter at @TheCQRC.

Learn More About Home Respiratory Therapies:

Millions of Americans are living with COPD and Obstructive Sleep Apnea, experiencing acute respiratory failure, or living with neuromuscular diseases. These individuals rely upon home respiratory therapies to remain at home. Learn more about home respiratory therapies and how they can help.

Stay in Touch:

Subscribe to our newsletter